Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 747

Results For "AI"

8352 News Found

Moderna and Metagenomi partner to develop next-gen in vivo gene editing therapeutics
Biotech | November 03, 2021

Moderna and Metagenomi partner to develop next-gen in vivo gene editing therapeutics

The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies


Lonza to acquire Exosomics service unit in Italy
Biotech | November 03, 2021

Lonza to acquire Exosomics service unit in Italy

Expertise in exosomes isolation and characterization will drive innovation in this field


Lancet endorses Sputnik Light for safety and immune response
News | November 03, 2021

Lancet endorses Sputnik Light for safety and immune response

Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries


WHO issues emergency use listing for Covaxin
News | November 03, 2021

WHO issues emergency use listing for Covaxin

This is the eighth Covid-19 vaccine to receive Emergency Use Listing


Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia
Biotech | November 02, 2021

Novavax and Serum Institute receive EUA for Covid-19 vaccine in Indonesia

The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice


Thermo Fisher Scientific realigns product portfolio
Medical Device | November 02, 2021

Thermo Fisher Scientific realigns product portfolio

Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific


AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
Biotech | November 02, 2021

AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma

The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio


Built-for-purpose offering for biomolecule attribute monitoring
Medical Device | November 02, 2021

Built-for-purpose offering for biomolecule attribute monitoring

The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity


SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
Digitisation | November 02, 2021

SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers

New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation


Caplin Point Labs posts  Q2FY22 PAT at Rs 74.98 Cr
News | November 02, 2021

Caplin Point Labs posts Q2FY22 PAT at Rs 74.98 Cr

The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021